Arthur R Barlow, CRNFA Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 502 W Highland Blvd, Inverness, FL 34452 Phone: 352-344-6577 |
Mrs. Melanie L Dryden, ARNP-C Registered Nurse - Maternal Newborn Medicare: Accepting Medicare Assignments Practice Location: 800 Medical Ct E, Inverness, FL 34452 Phone: 352-726-7667 Fax: 352-726-8193 |
Mark Eldon Johnston, FNP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 502 W Highland Blvd, Inverness, FL 34452 Phone: 352-726-1551 |
Natalie Baum, APRN, FNP-C Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 502 W Highland Blvd, Inverness, FL 34452 Phone: 352-726-1551 |
Roxanne A Phillip, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 415 Hunting Lodge Dr, Inverness, FL 34453 Phone: 813-857-7699 |
Mrs. Tammie Marie Leydig, CNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 214 S Apopka Ave, Inverness, FL 34452 Phone: 352-508-7310 Fax: 833-905-0111 |
Mrs. Lydia Dolores Mclaurin, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 120 N Montgomery Ave, Inverness, FL 34450 Phone: 352-726-1731 Fax: 352-637-5397 |
Mr. James Robert Aemisegger, ARNP Registered Nurse - Emergency Medicare: Accepting Medicare Assignments Practice Location: 401 N Central Ave, Inverness, FL 34453 Phone: 352-419-6526 Fax: 352-419-8966 |
Mrs. Nikalina Leliea Dundas, MSN, APRN, FNP-C Registered Nurse - Emergency Medicare: Medicare Enrolled Practice Location: 1907 Highway 44 W, Inverness, FL 34453 Phone: 352-344-2273 |
News Archive
BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.
Idiopathic pulmonary fibrosis (IPF) is a fatal disease in which progressive scarring of the lungs leads to respiratory failure. Lung scarring in IPF takes the form of aggregates of proliferating fibroblasts and myofibroblasts, known as "fibroblastic foci", which deposit collagen and other fibrotic components. These foci are thought to form in response to lung injury.
Researchers from Mount Sinai School of Medicine have developed a new computational method that will make it easier for scientists to identify and prioritize genes, drug targets, and strategies for repositioning drugs that are already on the market. By mining large datasets more simply and efficiently, researchers will be able to better understand gene-gene, protein-protein, and drug/side-effect interactions. The new algorithm will also help scientists identify fellow researchers with whom they can collaborate.
Scientists from Virginia Commonwealth University Massey Cancer Center have revealed how two genes interact to kill a wide range of cancer cells. Originally discovered by the study's lead investigator Paul B. Fisher, M.Ph., Ph.D., the genes known as mda-7/IL-24 and SARI could potentially be harnessed to treat both primary and metastatic forms of brain, breast, colon, lung, ovary, prostate, skin and other cancers.
› Verified 4 days ago